In conclusion, the present study demonstrated that pretreatment serum AAPR, tumor size, clinical nodal status, histological grade, PR and Ki67 expression were independent predictive factors for pCR in breast cancer patients treated with NAC. The gene discussed is MKI67; the disease is breast cancer.